Cancer Research AACR Conference on Molecular Diagnostics - 2008 Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Flesken-Nikitin, A.
Right arrow Articles by Nikitin, A. Yu.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Flesken-Nikitin, A.
Right arrow Articles by Nikitin, A. Yu.
[Cancer Research 63, 3459-3463, July 1, 2003]
© 2003 American Association for Cancer Research

Advances in Brief

Induction of Carcinogenesis by Concurrent Inactivation of p53 and Rb1 in the Mouse Ovarian Surface Epithelium1

Andrea Flesken-Nikitin2, Kyung-Chul Choi2,3, Jessica P. Eng, Elena N. Shmidt and Alexander Yu. Nikitin4

Department of Biomedical Sciences, Cornell University, Ithaca, New York 14853-6401

Alterations in p53 and Rb pathways are observed frequently in epithelial ovarian cancer (EOC).However, their roles in EOC initiation remain uncertain. Using a single intrabursal administration of recombinant adenovirus expressing Cre, we demonstrate that concurrent inactivation of p53 and Rb1 is sufficient for reproducible induction of ovarian epithelial carcinogenesis in mice homozygous for conditional gene alleles. Similarly to progression of disease in women, ovarian neoplasms spread i.p., forming ascites, and metastasize to the contralateral ovary, the lung, and the liver. These results establish critical interactions between p53 and Rb1 pathways in EOC pathogenesis, and provide a genetically defined immunocompetent mouse model of sporadic EOC.




This article has been cited by other articles:


Home page
 Cancer Res.Home page
T. Daikoku, Y. Hirota, S. Tranguch, A. R. Joshi, F. J. DeMayo, J. P. Lydon, L. H. Ellenson, and S. K. Dey
Conditional Loss of Uterine Pten Unfailingly and Rapidly Induces Endometrial Cancer in Mice
Cancer Res., July 15, 2008; 68(14): 5619 - 5627.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
Y. Wang, Z. Zhang, Y. Lu, R. Yao, D. Jia, W. Wen, M. LaRegina, K. Crist, R. Lubet, and M. You
Enhanced Susceptibility to Chemical Induction of Ovarian Tumors in Mice with a Germ Line p53 Mutation
Mol. Cancer Res., January 1, 2008; 6(1): 99 - 109.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol PatholHome page
A. Flesken-Nikitin, I. Toshkov, J. Naskar, K. M. Tyner, R. M. Williams, W. R. Zipfel, E. P. Giannelis, and A. Yu. Nikitin
Toxicity and Biomedical Imaging of Layered Nanohybrids in the Mouse
Toxicol Pathol, October 1, 2007; 35(6): 804 - 810.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
D. C. Corney, A. Flesken-Nikitin, A. K. Godwin, W. Wang, and A. Yu. Nikitin
MicroRNA-34b and MicroRNA-34c Are Targets of p53 and Cooperate in Control of Cell Proliferation and Adhesion-Independent Growth
Cancer Res., September 15, 2007; 67(18): 8433 - 8438.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. E. Burdette, R. M. Oliver, V. Ulyanov, S. M. Kilen, K. E. Mayo, and T. K. Woodruff
Ovarian Epithelial Inclusion Cysts in Chronically Superovulated CD1 and Smad2 Dominant-Negative Mice
Endocrinology, August 1, 2007; 148(8): 3595 - 3604.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Andreu-Vieyra, R. Chen, and M. M. Matzuk
Effects of Granulosa Cell-Specific Deletion of Rb in Inha-{alpha} Null Female Mice
Endocrinology, August 1, 2007; 148(8): 3837 - 3849.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhou, A. Flesken-Nikitin, and A. Yu. Nikitin
Prostate Cancer Associated with p53 and Rb Deficiency Arises from the Stem/Progenitor Cell-Enriched Proximal Region of Prostatic Ducts
Cancer Res., June 15, 2007; 67(12): 5683 - 5690.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
W.-L. Yang, K. Q. Cai, J. L. Smedberg, E. R. Smith, A. Klein-Szanto, T. C. Hamilton, and X.-X. Xu
A Reduction of Cyclooxygenase 2 Gene Dosage Counters the Ovarian Morphological Aging and Tumor Phenotype in Wv Mice
Am. J. Pathol., April 1, 2007; 170(4): 1325 - 1336.
[Abstract] [Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
W. Wang, M. Warren, and A. Bradley
From the Cover: Induced mitotic recombination of p53 in vivo
PNAS, March 13, 2007; 104(11): 4501 - 4505.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
Y.-C. SONG, S.-H. KIM, Y.-S. JUHNN, and Y.-S. SONG
Apoptotic Effect of Celecoxib Dependent Upon p53 Status in Human Ovarian Cancer Cells
Ann. N.Y. Acad. Sci., January 1, 2007; 1095(1): 26 - 34.
[Abstract] [Full Text] [PDF]

Home page
 Mol Cancer ResHome page
C. DelloRusso, P. L. Welcsh, W. Wang, R. L. Garcia, M.-C. King, and E. M. Swisher
Functional Characterization of a Novel BRCA1-Null Ovarian Cancer Cell Line in Response to Ionizing Radiation
Mol. Cancer Res., January 1, 2007; 5(1): 35 - 45.
[Abstract] [Full Text] [PDF]

Home page
 CarcinogenesisHome page
G. Yang, D. G. Rosen, I. Mercado-Uribe, J. A. Colacino, G. B. Mills, R. C. Bast Jr, C. Zhou, and J. Liu
Knockdown of p53 combined with expression of the catalytic subunit of telomerase is sufficient to immortalize primary human ovarian surface epithelial cells
Carcinogenesis, January 1, 2007; 28(1): 174 - 182.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
M. Singh and L. Johnson
Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
Clin. Cancer Res., September 15, 2006; 12(18): 5312 - 5328.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z. Zhou, A. Flesken-Nikitin, D. C. Corney, W. Wang, D. W. Goodrich, P. Roy-Burman, and A. Yu. Nikitin
Synergy of p53 and Rb Deficiency in a Conditional Mouse Model for Metastatic Prostate Cancer
Cancer Res., August 15, 2006; 66(16): 7889 - 7898.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
E. S. Knudsen and K. E. Knudsen
Retinoblastoma tumor suppressor: where cancer meets the cell cycle.
Experimental Biology and Medicine, July 1, 2006; 231(7): 1271 - 1281.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
D.-H. Yang, Z. Fazili, E. R. Smith, K. Q. Cai, A. Klein-Szanto, C. Cohen, I. R. Horowitz, and X.-X. Xu
Disabled-2 Heterozygous Mice Are Predisposed to Endometrial and Ovarian Tumorigenesis and Exhibit Sex-Biased Embryonic Lethality in a p53-Null Background
Am. J. Pathol., July 1, 2006; 169(1): 258 - 267.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Daikoku, S. Tranguch, I. N. Trofimova, D. M. Dinulescu, T. Jacks, A. Yu. Nikitin, D. C. Connolly, and S. K. Dey
Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer.
Cancer Res., March 1, 2006; 66(5): 2527 - 2531.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. Ruiz, M. Santos, M. F. Lara, C. Segrelles, C. Ballestin, and J. M. Paramio
Unexpected Roles for pRb in Mouse Skin Carcinogenesis
Cancer Res., November 1, 2005; 65(21): 9678 - 9686.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
T. Daikoku, D. Wang, S. Tranguch, J. D. Morrow, S. Orsulic, R. N. DuBois, and S. K. Dey
Cyclooxygenase-1 Is a Potential Target for Prevention and Treatment of Ovarian Epithelial Cancer
Cancer Res., May 1, 2005; 65(9): 3735 - 3744.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
L. Hernandez, S. Bea, M. Pinyol, G. Ott, T. Katzenberger, A. Rosenwald, F. Bosch, A. Lopez-Guillermo, J. Delabie, D. Colomer, et al.
CDK4 and MDM2 Gene Alterations Mainly Occur in Highly Proliferative and Aggressive Mantle Cell Lymphomas with Wild-type INK4a/ARF Locus
Cancer Res., March 15, 2005; 65(6): 2199 - 2206.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
G. D'Andrilli, C. Kumar, G. Scambia, and A. Giordano
Cell Cycle Genes in Ovarian Cancer: Steps Toward Earlier Diagnosis and Novel Therapies
Clin. Cancer Res., December 15, 2004; 10(24): 8132 - 8141.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
S. L. Stewart, T. D. Querec, A. R. Ochman, B. N. Gruver, R. Bao, J. S. Babb, T. S. Wong, T. Koutroukides, A. D. Pinnola, A. Klein-Szanto, et al.
Characterization of a Carcinogenesis Rat Model of Ovarian Preneoplasia and Neoplasia
Cancer Res., November 15, 2004; 64(22): 8177 - 8183.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2003 by the American Association for Cancer Research.